Content about Wendland

November 27, 2012

New product launches may be the lifeblood of the health-and-beauty aid industry, but most new product introductions reach only a modicum of success. Hamacher Resource Group VP Dave Wendland explores some of the pitfalls to avoid in launching a new product to market and offers measures companies can take to improve their innovation success rates in this interview with DSN. Wendland also discussed the topic in his recent blog, "New product launches: Lessons for success."

AUDIO Q&A: Hamacher Resource Group VP Dave Wendland explores some of the pitfalls to avoid in launching a new product to market and offers measures companies can take to improve their innovation success rates in this interview with DSN. New product launches may be the lifeblood of the health-and-beauty aid industry, but most new product introductions reach only a modicum of success.

October 29, 2013

Hamacher Resource Group VP Dave Wendland is moderating Drug Store News' Diabetes & Chronic Care Roundtable for the 10th consecutive year, the company said Tuesday.

WAUKESHA, Wis. — Hamacher Resource Group VP Dave Wendland is moderating Drug Store News' Diabetes & Chronic Care Roundtable for the 10th-consecutive year, the company said Tuesday.

The roundtable, part of the DSN Industry Issues Summit, will take place on Dec. 3 at the New York Athletic Club in New York and include participants like Walgreens, Thrifty-White, Costco, H-E-B, Ahold, Kerr Drug, AmerisourceBergen and McKesson/Health Mart, as well as numerous suppliers.